Abstract:Developing therapeutic strategies to modulate the activity of all prevalent variants (wild-type, HAQ, R232H, AQ, and R293Q) of the stimulator of interferon genes (STING) is still of great interest to treating immune-related diseases. Herein, we synthesized six novel deoxyinosine-mixed deoxyribose cyclic dinucleotide prodrugs (SATE-dCDN) including a combination of hypoxanthine and other bases (A, U, C, T, and G) for a cell-based in vitro assay. The HPLC assay indicated that deoxyinosine-mixed SATE (S-acylthioalkyl ester)-dCDN prodrugs retained high serum stability. The IRF3-responsive luciferase assay in THP1-Lucia cells showed that the activity of the prodrugs with purine bases (SATE-3',3'-c-di-dIMP, SATE-3',3'-c-di-dIdAMP, and SATE-3',3'-c-di-dIdGMP) was higher than that of the prodrugs with pyrimidine bases (SATE-3',3'-c-di-dIdUMP, SATE-3',3'-c-di-dIdTMP, and SATE-3',3'-c-di-dIdCMP), among which prodrug 14a (SATE-3',3'-c-di-dIdAMP) with hypoxanthine and adenine bases exhibited the highest activity with an EC50 value of 0.046 μM. The IRF3 responsive dual-luciferase reporter assay in HEK293T cells transfected with plasmids expressing different STING variants further showed that prodrug 14a could activate all five most common hSTING variants, including the refractory hSTINGR232H and hSTINGQ variants. Furthermore, prodrug 14a also induced the production of the highest levels of mRNA of IFN-β, CXCL10, IL-6 and TNF-α through STING-dependent IRF and NF-κB signaling pathways in THP-1 cells. These results suggested that the combination of deoxyinosine with a SATE-dCDN prodrug could modulate the broad-spectrum activity of all common STING variants.

Synthesis of Original Cyclic Dinucleotide Analogues Using the Sulfo-click Reaction

Design, Synthesis and Biological Evaluation of (2′,5′ and 3′5′-Linked) cGAMP Analogs that Activate Stimulator of Interferon Genes (STING)

2',4'‐LNA‐Functionalized 5′‐S‐phosphorothioester CDNs as STING agonist

Chemical Evolution of Cyclic Dinucleotides: Perspective of the Analogs and Their Preparation

Exploration of the Binding Mechanism of Cyclic Dinucleotide Analogs to Stimulating Factor Proteins and the Implications for Subsequent Analog Drug Design

Supramolecular Cyclic Dinucleotide Nanoparticles for STING-Mediated Cancer Immunotherapy

Synthesis of All Possible Canonical (3 '-5 '-Linked) Cyclic Dinucleotides and Evaluation of Riboswitch Interactions and Immune-Stimulatory Effects

Design and syntheses of a bimolecular STING agonist based on the covalent STING antagonist

Chemical Synthesis, Purification, and Characterization of 3′-5′-linked Canonical Cyclic Dinucleotides (Cdns)

Progress on the Synthesis and Activity of Cyclic Dinucleotides As Stimulator of Interferon Gene (STING) Agonists

Synthesis and biological evaluation of all possible inosine-mixed cyclic dinucleotides that activate different hSTING variants

Design and Synthesis of Cyclic Dinucleotide Analogues Containing Triazolyl C-Nucleosides

Design, Synthesis and Systematic Evaluation of All Possible Cyclic Dinucleotides (cdns) That Activate Human Stimulator of Interferon Genes (STING) Variants

Cyclic Diguanylate Analogues: Facile Synthesis, STING Binding Mode and Anti-Tumor Immunity Delivered by Cytidinyl/cationic Lipid

Identification of Novel Carbocyclic Pyrimidine Cyclic Dinucleotide STING Agonists for Antitumor Immunotherapy Using Systemic Intravenous Route.

Distinct Dynamical and Conformational Features of Human STING in Response to 2'3'-cGAMP and c-di-GMP.

Fluorinated cGAMP analogs, which act as STING agonists and are not cleavable by poxins: Structural basis of their function

Structure−Activity Relationship Study of Benzothiophene Oxobutanoic Acid Analogues Leading to Novel Stimulator of Interferon Gene (STING) Agonists

Design, Synthesis, and Cell-Based in Vitro Assay of Deoxyinosine-Mixed SATE-dCDN Prodrugs That Activate All Common STING Variants

Discovery of Novel Thieno[2,3-d]imidazole Derivatives As Agonists of Human STING for Antitumor Immunotherapy Using Systemic Administration.

Design, Synthesis and Biological Evaluation of Acridone Analogues As Novel STING Receptor Agonists